Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2012-07-23 Earnings Release
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Generix Group announces first quarter revenues of financial year 2012/2013
Earnings Release Classification · 98% confidence The document explicitly states it is announcing the 'revenues for the first quarter, ended June 30, 2012, of its financial year 2012/2013.' It provides key financial highlights, including revenue figures broken down by segment (Licenses, Maintenance, SaaS, Consulting Services) for the quarter, and mentions profitability/EBITDA. This structure—a press release format focusing on period-specific financial results (Q1)—is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial announcement of the period's results. Q1 2013
2012-07-23 English
Generix Group annonce son chiffre d'affaires pour le premier trimestre de son exercice 2012/2013
Earnings Release Classification · 99% confidence The document explicitly states it is publishing the 'chiffre d'affaires au titre du premier trimestre, clos le 30 juin 2012' (revenue for the first quarter, ending June 30, 2012). It provides detailed, non-audited financial figures (revenue breakdown by Licenses, Maintenance, SaaS, etc.) for the quarter. This content structure—a press release announcing key quarterly financial highlights—perfectly matches the definition of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a full interim report (IR), but rather the initial announcement of period results. Q1 2012
2012-07-23 French
Generix Group : Déclaration de droits de vote et d'actions au 30 juin 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is dated July 9, 2012, and explicitly states it concerns the 'nombre total de droits de vote et d'actions' (total number of voting rights and shares) as required by French regulations (Article L. 233-8 II of the Commercial Code and Article 223-16 of the AMF General Regulation). It presents a table showing the number of shares and theoretical voting rights as of June 30, 2012. This content directly relates to the official declaration of voting rights and share capital structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it is a mandatory periodic disclosure regarding voting power.
2012-07-09 French
Bilan semestriel du contrat de liquidité GENERIX
Capital/Financing Update Classification · 99% confidence The document is dated July 9, 2012, and provides a 'Bilan semestriel' (Semi-annual balance sheet/report) concerning a liquidity contract ('contrat de liquidité') managed by NATIXIS for GENERIX shares, detailing the holdings (shares and cash) as of June 30, 2012, and comparing them to the previous semi-annual balance. This document is a periodic update specifically related to the company's share liquidity management, which falls under the scope of capital structure or share transactions. Since the document details the status of a liquidity contract (often related to share buybacks or stabilization), it most closely aligns with 'Transaction in Own Shares' (POS) or potentially 'Capital/Financing Update' (CAP). Given the specific focus on the liquidity contract balance, POS is the most precise fit, as liquidity contracts are mechanisms for managing share price/volume, which is a form of share transaction activity. The document is short and provides specific data, not just an announcement of a report, thus ruling out RPA/RNS.
2012-07-09 French
Generix Group : Avec Generix, Vet'Affaires mise sur la promotion et la fidélisation client en cross canal pour développer son réseau de franchises
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de Presse" (Press Release) and announces a business partnership between Generix Group and Vet'Affaires regarding customer loyalty and promotion software implementation. This type of announcement, detailing a business development, partnership, or general corporate news that doesn't fit specific financial reporting categories (like 10-K, ER, or DIV), typically falls under general regulatory announcements or press releases. Since it is not a formal financial report, a transcript, or a specific regulatory filing like DIRS or DVA, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements not covered elsewhere. The length (5128 chars) is substantial enough that it is the primary content, not just an announcement of content, ruling out RPA.
2012-06-27 French
Generix Group : Déclaration de droits de vote et d'actions au 31 mai 2012
Regulatory Filings Classification · 95% confidence The document is dated June 5, 2012, and explicitly references Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. It provides a table detailing the 'Nombre d'actions' (Number of shares) and 'Nombre de droits de vote théoriques' (Number of theoretical voting rights) as of May 31, 2012. This structure is characteristic of a mandatory disclosure regarding the total number of shares and voting rights, which falls under general regulatory announcements or specific disclosures related to capital structure/voting rights. Since there is no specific code for 'Total Voting Rights Disclosure' and it is a formal regulatory update, it fits best under Regulatory Filings (RNS) or potentially Share Issue/Capital Change (SHA) if interpreted broadly. However, given the specific nature of reporting voting rights under French law, RNS is the most appropriate general regulatory fallback category for such specific, non-periodic disclosures that aren't earnings or management changes. It is too specific for a general 'Share Issue' (SHA) and is not a dividend notice (DIV) or director dealing (DIRS).
2012-06-05 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.